Building on the success of Kurin Lock® technology, Kurin Jet is the culmination of years of market-leading innovation, reducing preventable blood culture contamination (BCC) faster and easier than ever before.* Passive technology complements clinician workflow, ensuring high levels of compliance and sustained outcomes.
Kurin Jet sidelines the initial 0.15 mL of blood, which may contain contaminants from the patient’s own skin, ensuring that the best possible blood specimen reaches the culture bottle. Clinical studies show that best practice compliance combined with Kurin collection can reduce BCC by more than 80% and drive hospital rates below the recommended 1% target.

.avif)
.avif)

.avif)















